This session explores some of the basic radiobiologic principles of radiopharmaceutical therapy.

As the interest and use of Radiopharmaceutical Therapy is rapidly growing, so too is the practice of dosimetry. However, the methods and applications vary widely from site to site and often from practitioner to practitioner.

In this session, expert speakers will discuss the future of theranostics. The speakers pay specific attention to the following topics: novel cancer-specific targets, novel pan-cancer targets, and the potential use of alpha emitters.

This session focuses on practical clinical challenges in the management of patients receiving radiopharmaceutical therapies (RPT).  Expert speakers discuss a broad range of common challenges related to radiation safety, renal and hematologic dysfunction, response assessment and decisions about di

While most oncologists are familiar with the development, execution and reporting of interventional clinical trials that improve patient outcomes, there are unique challenges that must be considered when evaluating radioactive drugs.

This session will review the latest science in the field of radiopharmaceutical therapy.

This session covers the experiences of the radiopharmaceutical therapy programs at three institutions.

This session explores critical operational, clinical and administrative considerations for maturing and optimizing established radiopharmaceutical and theranostics programs.

This session reviews the latest science in the field of radiopharmaceutical therapy.

Increasing access and addressing unmet needs are critical to the continued growth and adoption of radiopharmaceutical therapy. This session summarizes the current barriers to access and discuss solutions to increase physician and patient access to these important therapies.